Seeing Is Believing
Conatus Pharmaceuticals's activity chart (see below) currently has 20 price targets and 11 ratings on display.
Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 968.5 days.
Most recent stock forecast was given by from PIPER SANDLER on 26-Mar-2019. First documented stock forecast 19-Aug-2013.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 26-Mar-2019
$20
$19.44 (3471.43%)
7 years 5 months 17 days ago
(26-Mar-2019)
1/1 (100%)
$-222 (-91.74%)
422
Hold Since 22-Mar-2019
$8
$7.44 (1328.57%)
$14
7 years 5 months 21 days ago
(22-Mar-2019)
3/3 (100%)
$-248 (-96.88%)
736
Buy Since 06-Dec-2018
$10
$9.44 (1685.71%)
7 years 9 months 6 days ago
(06-Dec-2018)
1/1 (100%)
$-378 (-97.42%)
532
Hold Since 06-Dec-2018
$10
$9.44 (1685.71%)
7 years 9 months 6 days ago
(06-Dec-2018)
1/1 (100%)
$-378 (-97.42%)
532
Hold Since 24-Sep-2015
$5
$4.44 (792.86%)
$9
10 years 11 months 19 days ago
(24-Sep-2015)
2/2 (100%)
$-1163 (-99.57%)
1792
What is CNAT (Conatus Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on CNAT (Conatus Pharmaceuticals)?
Which analyst has the most public recommendations on CNAT (Conatus Pharmaceuticals)?
Which analyst is the currently most bullish on CNAT (Conatus Pharmaceuticals)?
Which analyst is the currently most reserved on CNAT (Conatus Pharmaceuticals)?